Another SPAC goes by the wayside as Innovatus ditches its blank check vehicle
The public market has not spared SPACs, which offer an alternative to the traditional IPO. In recent months, some have had mergers called off, while others have nixed plans to go public altogether.
Last week, Innovatus Life Sciences Acquisition, headed by David Schiff, announced it withdrew its $175 million IPO. Though the company did not cite any reasons for its withdrawal, the blank check company had initially filed in April 2021, when the market conditions looked drastically different and SPACs were surging.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.